Publications
- Hypoxia-mediated histone acetylation and expression of N-myc transcription factor dictate aggressiveness of neuroblastoma cells2014 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment2012 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment2012 | Second Faculty of Medicine
- Multilayered Polyurethane/Poly(vinyl alcohol) Nanofibrous Mats for Local Topotecan Delivery as a Potential Retinoblastoma Treatment2023 | Faculty of Science, Second Faculty of Medicine
- Apoferritin/vandetanib association is long-term stable but does not improve pharmacological properties of vandetanib2021 | Faculty of Science, Second Faculty of Medicine
- Miat is an upstream regulator of nmyc and the disruption of the miat/nmyc axis induces cell death in nmyc amplified neuroblastoma cell lines2021 | Second Faculty of Medicine
- Hydrogel implants for transscleral diffusion delivery of topotecan: In vivo proof of concept in a rabbit eye model2021 | Second Faculty of Medicine
- Drug Sequestration in Lysosomes as One of the Mechanisms of Chemoresistance of Cancer Cells and the Possibilities of Its Inhibition2020 | Second Faculty of Medicine
- Poly(D,L-lactide)/polyethylene glycol micro/nanofiber mats as paclitaxel-eluting carriers: preparation and characterization of fibers, in vitro drug release, antiangiogenic activity and tumor recurrence prevention2019 | Faculty of Science, Second Faculty of Medicine, Third Faculty of Medicine
- Ellipticine-loaded apoferritin nanocarrier retains DNA adduct-based cytochrome P450-facilitated toxicity in neuroblastoma cells2019 | Faculty of Science, Second Faculty of Medicine
Loading network view...